News from purdue pharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 10, 2019, 11:00 ET AKYNZEO® Oral now covered by the Ontario, Quebec and Non-Insured Health Benefits public drugs plans

PICKERING, ON, July 10, 2019 /CNW/ - Purdue Pharma (Canada) is pleased to announce that AKYNZEO® Oral is now reimbursed by the Ontario Public Drug Program and the Régie de l'assurance maladie du...


Mar 12, 2019, 15:05 ET FOQUEST® Receives Approval for Expanded Indication for Children and Adolescents with ADHD

First and only methylphenidate product approved in Canada that provides control of ADHD symptoms throughout the day PICKERING, ON, March 12, 2019 /CNW/ - Purdue Pharma (Canada) announced today that...


Jan 22, 2019, 08:30 ET Klaria signs exclusive development, license and supply agreements with Purdue Pharma (Canada) for the emergency treatment of anaphylactic reactions (KL-01401)

UPPSALA, Sweden and PICKERING, ON, Jan. 22, 2019 /CNW/ - Klaria AB (Klaria) (Parent Company, Klaria Pharma Holding AB, Stockholm OMX Nasdaq:KLAR) and Purdue Pharma (Canada) today announced they have...


Sep 04, 2018, 11:00 ET BETADINE® - A New Treatment Option for Canadians for Oral Infections - Now Available in Canada

PICKERING, ON, Sept. 4, 2018 /CNW/ - Purdue Pharma (Canada) announces today that BETADINE® Sore Throat Spray and BETADINE® Sore Throat Gargle launched on August 3, 2018. BETADINE® Sore Throat Spray...


Apr 10, 2018, 07:00 ET PENTHROX® Receives Marketing Authorization from Health Canada for Adult Patients Requiring Relief from Moderate to Severe Acute Pain Associated with Trauma or Interventional Medical Procedures

PICKERING, ON, April 10, 2018 /CNW/ - Purdue Pharma (Canada) and Medical Developments International Limited (MDI), announce today that PENTHROX®, a low dose methoxyflurane, has been granted marketing ...


Feb 01, 2018, 10:00 ET New Treatment Option for Adults With ADHD: FOQUEST® (Methylphenidate Controlled Release Capsules) Now Available in Canada

First and only methylphenidate product approved in Canada with a 16-hour duration of action PICKERING, ON, Feb. 1, 2018 /CNW/ - Purdue Pharma (Canada) today announced the Canadian commercial...


Jan 30, 2018, 08:00 ET BELBUCA® - A New Treatment Option for Canadians Living With Chronic Pain - Now Available in Canada

PICKERING, ON, Jan. 30, 2018 /CNW/ - Purdue Pharma (Canada) and BioDelivery Sciences International Inc. (BDSI) announce today that BELBUCA® (buprenorphine buccal soluble film) is now commercially...


Nov 28, 2017, 08:00 ET New single capsule treatment AKYNZEO™ now available for the prevention of chemotherapy-induced nausea and vomiting in Canada

PICKERING, ON, Nov. 28, 2017 /CNW/ - Purdue Pharma (Canada) announce today that AKYNZEO™ (netupitant/palonosetron hydrochloride) capsules are now available to Canadian cancer patients for the...


Sep 25, 2017, 11:00 ET David A. Pidduck Appointed President and CEO of Purdue Pharma (Canada)

Pickering, ON, Sept. 25, 2017 /CNW/ - David A. Pidduck has been appointed as President and Chief Executive Officer of Purdue Pharma (Canada) with immediate effect. Since joining the company in 2014,...


Aug 09, 2017, 08:30 ET Klaria signs exclusive development, license and supply agreement with Purdue Pharma (Canada) for acute treatment of opioid overdose (KL-00514)

UPPSALA, Sweden and PICKERING, ON, Aug. 9, 2017 /CNW/ – Klaria AB (Klaria) (Parent Company, Klaria Pharma Holding AB, Stockholm OMX Nasdaq:KLAR) and Purdue Pharma (Canada) today announce they have...


Jul 12, 2017, 07:30 ET BioDelivery Sciences Signs Exclusive Agreement With Purdue Pharma (Canada) for the Licensing and Distribution Rights of BELBUCA® in Canada

RALEIGH, NC and PICKERING, ON, July 12, 2017 /CNW/ - Today, BioDelivery Sciences International Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction...


Jul 05, 2017, 14:00 ET Purdue Pharma (Canada) appoints Dr. Tom Koutsavlis as new Vice President, Research and Development

PICKERING, ON, July 5, 2017 /CNW/ - Dr. Tom Koutsavlis, MD, MSc, FRCPC, MBA, has joined Purdue Pharma (Canada) as Vice President, Research and Development (R&D). Tom brings to Purdue Pharma (Canada)...


Jun 06, 2017, 07:30 ET Helsinn Group signs Exclusive Agreement with Purdue Pharma (Canada) for the Distribution and Licensing Rights of Aloxi® (palonosetron hydrochloride) in Canada

LUGANO, Switzerland and PICKERING, ON, June 6, 2017 /CNW/ - Helsinn Group and Purdue Pharma (Canada) today announce that they have signed a distribution and licence agreement granting Purdue Pharma...


May 30, 2017, 09:30 ET Purdue Pharma (Canada) appoints Carina Vassilieva as new Vice President, Human Resources

PICKERING, ON, May 30, 2017 /CNW/ - Carina Vassilieva, M.B.A., C.C.P., G.R.P., has joined Purdue Pharma (Canada) as Vice President, Human Resources, effective today. Carina brings to Purdue Pharma...


Sep 11, 2016, 20:46 ET Medical Developments International Limited Signs Exclusive Licensing and Distribution Agreement with Purdue Pharma Canada for Penthrox® in Canada

PICKERING, ON and VICTORIA, Australia, Sept. 11, 2016 /CNW/ - Medical Developments International Limited ("MDI") (ASX: MVP) is delighted to announce it has reached an exclusive distribution and...


Apr 25, 2016, 06:00 ET Helsinn Group signs exclusive agreement with Purdue Pharma Canada for the distribution and licensing rights of Akynzeo® (netupitant/palonosetron combo) in Canada

LUGANO, Switzerland and PICKERING, Canada, April 25, 2016 /CNW/ - Helsinn, the Swiss Group focused on building quality cancer care products and Purdue Pharma Canada today announce that they have...


Apr 11, 2016, 13:55 ET Purdue Pharma Canada announces the appointment of John Sebben as Vice President, Manufacturing Operations

Purdue Pharma Canada today announced the appointment of John Sebben as Vice President, Manufacturing Operations PICKERING, ON, April 11, 2016 /CNW/ - John Sebben has joined Purdue as Vice President,...


Apr 06, 2016, 09:48 ET Purdue Pharma Canada Expresses Disappointment in reaction to Health Canada decision to not proceed with proposed regulations requiring tamper resistance for Oxycodone

PICKERING, ON, April 6, 2016 /CNW/ - Purdue Pharma Canada is disappointed by the decision and subsequent statement issued by Health Canada on April 4th, 2016 to not proceed with the proposed...


Mar 22, 2016, 06:00 ET Purdue Pharma Canada Joins the NEOMED Institute As an Industrial Partner

MONTREAL, and PICKERING, ON, March 22, 2016 /CNW/ - Purdue Pharma Canada, a pharmaceutical company dedicated to developing and providing innovative medicines for patients and healthcare...


Jan 11, 2016, 09:00 ET Purdue Pharma Canada announces the appointment of Dr. Julie Ducharme as Vice President, Research and Development

PICKERING, ON, Jan. 11, 2016 /CNW/ - Purdue Pharma Canada today announced the appointment of Dr. Julie Ducharme as Vice President, Research and Development. "Dr. Ducharme is a dynamic leader with a...


Dec 09, 2015, 09:00 ET Purdue Canada diversifies its portfolio by acquiring Merck's ophthalmology franchise as part of a multiregional agreement led by Mundipharma

Acquisition highlights: Acquired portfolio consists of COSOPT®, COSOPT® Preservative-Free, TIMOPTIC®, TIMOPTIC XE®, TIMOPTIC® Preservative‑Free, TRUSOPT® and TRUSOPT® Preservative‑Free Agreement...


Feb 04, 2015, 09:00 ET Purdue Pharma Canada announces the appointment of Dr. Rami Batal as Vice President, Business Development

PICKERING, ON, Feb. 4, 2015 /CNW/ - Purdue Pharma Canada today announced the appointment of Dr. Rami Batal as Vice President, Business Development. Dr. Batal brings to Purdue more than 15 years of...


Oct 27, 2014, 09:00 ET Purdue Pharma Canada announces the appointment of Kelly A. Martin as Vice President, Finance and Chief Financial Officer

PICKERING, ON, Oct. 27, 2014 /CNW/ - Purdue Pharma Canada today announced the appointment of Ms. Kelly Martin as Vice President, Finance and Chief Financial Officer. Kelly brings 25 years of...


May 15, 2014, 11:24 ET Purdue Pharma Canada announces the appointment of Grant D. Perry as Vice President of Government and Corporate Affairs

PICKERING, ON, May 15, 2014 /CNW/ - Purdue Pharma Canada today announced the appointment of Grant Perry to the position of Vice President, Government and Corporate Affairs, effective May 15, 2014. In ...


Jan 27, 2014, 08:00 ET Purdue Pharma Canada announces the appointment of David A. Pidduck as Vice President of Marketing & Health Solutions

PICKERING, ON, Jan. 27, 2014 /CNW/ - Purdue Pharma Canada today announced the appointment of David A. Pidduck to the position of Vice President, Marketing and Health Solutions, effective January 27,...